CLINICAL_TRIALS
trial_result
· 2021-03-01
Clinical Trial Update: Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients [Phase 4]
Summary
Phase 4 trial evaluating human urinary kallidinogenase for acute ischemic stroke shows results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Second Hospital of Hebei Medical University | Conditions: Stroke, Acute | Phase 4 | Status: COMPLETED | Results posted: 2021-03-01